138 related articles for article (PubMed ID: 35119307)
1. Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.
Prajapati SC; Dunham N; Fan H; Garrett-Bakelman FE
Biotechniques; 2022 Mar; 72(3):81-84. PubMed ID: 35119307
[TBL] [Abstract][Full Text] [Related]
2. Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia.
Rathe SK; Moriarity BS; Stoltenberg CB; Kurata M; Aumann NK; Rahrmann EP; Bailey NJ; Melrose EG; Beckmann DA; Liska CR; Largaespada DA
Sci Rep; 2014 Aug; 4():6048. PubMed ID: 25116387
[TBL] [Abstract][Full Text] [Related]
3. Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML.
Kurata M; Rathe SK; Bailey NJ; Aumann NK; Jones JM; Veldhuijzen GW; Moriarity BS; Largaespada DA
Sci Rep; 2016 Nov; 6():36199. PubMed ID: 27808171
[TBL] [Abstract][Full Text] [Related]
4. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells.
Li N; Jia X; Wang J; Li Y; Xie S
Mol Med Rep; 2015 Nov; 12(5):6861-6. PubMed ID: 26397212
[TBL] [Abstract][Full Text] [Related]
6. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
[TBL] [Abstract][Full Text] [Related]
7. Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.
Malani D; Murumägi A; Yadav B; Kontro M; Eldfors S; Kumar A; Karjalainen R; Majumder MM; Ojamies P; Pemovska T; Wennerberg K; Heckman C; Porkka K; Wolf M; Aittokallio T; Kallioniemi O
Leukemia; 2017 May; 31(5):1187-1195. PubMed ID: 27833094
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
Xie XT; Jiang SY; Li BS; Yang LL
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia.
Freisleben F; Behrmann L; Thaden V; Muschhammer J; Bokemeyer C; Fiedler W; Wellbrock J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708452
[TBL] [Abstract][Full Text] [Related]
10. Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K
Lowinus T; Heidel FH; Bose T; Nimmagadda SC; Schnöder T; Cammann C; Schmitz I; Seifert U; Fischer T; Schraven B; Bommhardt U
Cell Commun Signal; 2019 Jan; 17(1):5. PubMed ID: 30651113
[TBL] [Abstract][Full Text] [Related]
11. Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
Levin M; Stark M; Berman B; Assaraf YG
Cell Death Dis; 2019 May; 10(6):390. PubMed ID: 31101804
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia.
Bhise NS; Elsayed AH; Cao X; Pounds S; Lamba JK
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 31022985
[TBL] [Abstract][Full Text] [Related]
13. Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
Shah K; Mirza S; Desai U; Jain N; Rawal R
Anticancer Agents Med Chem; 2016; 16(1):128-35. PubMed ID: 26278546
[TBL] [Abstract][Full Text] [Related]
14. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.
Valletta S; Dolatshad H; Bartenstein M; Yip BH; Bello E; Gordon S; Yu Y; Shaw J; Roy S; Scifo L; Schuh A; Pellagatti A; Fulga TA; Verma A; Boultwood J
Oncotarget; 2015 Dec; 6(42):44061-71. PubMed ID: 26623729
[TBL] [Abstract][Full Text] [Related]
15. Cytarabine-Resistant
Ko YC; Hu CY; Liu ZH; Tien HF; Ou DL; Chien HF; Lin LI
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862120
[TBL] [Abstract][Full Text] [Related]
16. A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.
Hou P; Wu C; Wang Y; Qi R; Bhavanasi D; Zuo Z; Dos Santos C; Chen S; Chen Y; Zheng H; Wang H; Perl A; Guo D; Huang J
Cancer Res; 2017 Aug; 77(16):4402-4413. PubMed ID: 28625976
[TBL] [Abstract][Full Text] [Related]
17. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
[TBL] [Abstract][Full Text] [Related]
18. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
Lee DH; Kang SH; Choi DS; Ko M; Choi E; Ahn H; Min H; Oh SJ; Lee MS; Park Y; Jin HS
Cancer Lett; 2021 Jul; 510():37-47. PubMed ID: 33872695
[TBL] [Abstract][Full Text] [Related]
19. Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.
Ruvolo PP; Ma H; Ruvolo VR; Zhang X; Mu H; Schober W; Hernandez I; Gallardo M; Khoury JD; Cortes J; Andreeff M; Post SM
Haematologica; 2017 Dec; 102(12):2048-2057. PubMed ID: 28912176
[TBL] [Abstract][Full Text] [Related]
20. The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia.
Mihaila RG; Topircean D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):249-257. PubMed ID: 34446939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
